Stocktoria
BioScience Health Innovations, Inc. BHIC
BioScience Health Innovations, Inc. (BHIC) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $5.7M at a 11.3% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Services · percentile among 867 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Detailed pages
Sector peers · similar-size Services companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BHIC | BioScience Health Innovations, Inc. | 4/9 | — | — | — |
| DTCX | Datacentrex, Inc. | 4/9 | — | — | — |
| GLE | Global Engine Group Holding Ltd | 2/9 | 8.35 | — | -94.1% |
| PHUN | Phunware, Inc. | 1/9 | -0.56 | — | — |
| HTCR | HeartCore Enterprises, Inc. | 4/9 | -1.89 | 0.8 | -70.5% |
| SHAZ | SharonAI Holdings Inc. | 2/9 | -4.35 | — | — |
| DTST | Data Storage Corp | 2/9 | — | — | — |
FAQ
Is BHIC financially healthy?
BioScience Health Innovations, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does BHIC pay a dividend?
No, BioScience Health Innovations, Inc. does not currently pay a dividend.
How profitable is BHIC?
In FY2025, BioScience Health Innovations, Inc. had a net margin of 11.3% and a return on equity of 43.5%.
Source: SEC EDGAR filings · CIK 0001784440 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.